Rabbit Polyclonal SIX4 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human Homeobox protein SIX4 aa 700 to C-terminus.
View Alternative Names
Homeobox protein SIX4, Sine oculis homeobox homolog 4, SIX4
- IP
Supplier Data
Immunoprecipitation - Anti-SIX4 antibody (AB176713)
SIX4 was immunoprecipitated from 1mg HeLa whole cell lysate using ab176713 at 6 μg/mg lysate (Lane 2), a rabbit anti-SIX4 antibody recognizing an upstream epitope (Lane 1) or control IgG (Lane 3). 20% of the Immunoprecipitate was loaded per lane and then immunobotted using ab176713 at 0.4 μg/ml.
Detection : Chemiluminescence with exposure time of 3 seconds.
All lanes:
Immunoprecipitation - Anti-SIX4 antibody (ab176713)
Predicted band size: 83 kDa
true
Exposure time: 3s
- WB
Supplier Data
Western blot - Anti-SIX4 antibody (AB176713)
All lanes:
Western blot - Anti-SIX4 antibody (ab176713) at 0.04 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
HeLa whole cell lysate at 15 µg
Lane 3:
293T whole cell lysate at 50 µg
Predicted band size: 83 kDa
true
Exposure time: 30s
- WB
CiteAb
Western blot - Anti-SIX4 antibody (AB176713)
SIX4 western blot using anti-SIX4 antibody ab176713. Publication image and figure legend from Wang, Z., Sun, B. S., et al., 2022, Anal Cell Pathol (Amst), PubMed 35498155.
ab176713 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab176713 please see the product overview.
Knockdown of FOXA1 inhibits SIX4 expression in CC cells. (a) SIX4 was predicted to be a downstream gene of FOXA1 using hTFtarget database. (b) High expression of SIX4 in CESC in TCGA database. (c) Conserved binding sites for FOXA1. (d) Potential binding sites of SIX4 promoter to FOXA1. (e) SIX4 expression in TCGA-CESC database. (f) Detection of SIX4 mRNA expression in normal cervical epithelial cells H8 and CC cell lines (HT-3, CaSki, HeLa, and SiHa) by RT-qPCR. (g) Detection of SIX4 protein expression in drug-resistant cells after knockdown of FOXA1 measured using Western blot. (h) The effect of low expression of FOXA1 on the Promoter luciferase activity of SIX4 measured using dual-luciferase assay. (i) The ability of anti-FOXA1 to enrich SIX4 promoter sequence examined using ChIP assay. Data among multiple groups were analyzed by one-way or two-way ANOVA followed by Tukey's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001). The cell experiment was independently repeated three times.
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SIX4 protein facilitates the regulation of genes involved in developmental processes including somitogenesis and myogenesis. It associates with other transcription factors as part of protein complexes to execute its role effectively. Its function is vital in the proper formation of muscle tissue and the development of sensory organs ensuring that cells differentiate as required during growth.
Pathways
SIX4 participates in the Pax-Six-Eya-Dach network which is essential for early organogenesis and cell differentiation. It interacts with Pax family proteins like PAX3 and PAX7 integrating signals that control the activation of downstream genes important for organ development. Additionally SIX4 is involved in the Wnt signaling pathway which maintains stem cell populations and influences cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Skeletal muscle 14:30 PubMed39627769
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 27:259-265 PubMed36601689
2023
Applications
Unspecified application
Species
Unspecified reactive species
Analytical cellular pathology (Amsterdam) 2022:9675466 PubMed35498155
2022
Applications
Unspecified application
Species
Unspecified reactive species
Thoracic cancer 12:752-759 PubMed33481352
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell biochemistry and function 38:66-76 PubMed31702057
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com